Related Experiment Video
Updated: Dec 29, 2025
06:01
Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction
Published on: October 6, 2022
1.7K
A novel UTMD system facilitating nucleic acid delivery into MDA-MB-231 cells
Hui Zhang1,2, Yue Li1,2, Fang Rao2
1Laboratory of Ultrasound Molecular Imaging, Department of Ultrasound Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China.
Bioscience Reports
|January 29, 2020
Summary
Ultrasound targeted microbubble destruction (UTMD) offers a safe, low-cost, non-viral method for gene delivery. This technique efficiently transports genetic material into breast cancer cells, showing promise for future gene therapy applications.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Oncology
Background:
- Gene therapy requires safe and efficient nucleic acid delivery.
- Non-viral methods are crucial for therapeutic applications.
- Ultrasound targeted microbubble destruction (UTMD) is a novel gene delivery tool.
Purpose of the Study:
- To explore UTMD for low-cost, non-viral gene transfection in MDA-MB-231 cells.
- To evaluate the efficiency and safety of delivering pEGFP and miR-34a mimic via UTMD.
- To assess the therapeutic potential of UTMD in breast cancer gene therapy.
Main Methods:
- Utilized ultrasound targeted microbubble destruction (UTMD) technology.
- Optimized ultrasonic parameters: 0.6 W/cm² acoustic intensity, 20s exposure time, 20% duty cycle.
- Delivered plasmid DNA (pEGFP) and microRNA-34a (miR-34a) mimic into MDA-MB-231 cells.
Main Results:
- UTMD achieved >40% transfection efficiency for pEGFP.
- Cell viability was maintained under optimized UTMD conditions.
- Successfully delivered miR-34a mimic, inhibiting proliferation and inducing apoptosis in MDA-MB-231 cells.
Conclusions:
- UTMD is an efficient and safe non-viral gene delivery method for breast cancer cells.
- UTMD facilitates the delivery of both plasmid DNA and microRNA mimics.
- Further in vivo studies are warranted to explore UTMD-mediated gene therapy.
